A detailed history of Curbstone Financial Management Corp transactions in Novartis Ag stock. As of the latest transaction made, Curbstone Financial Management Corp holds 4,044 shares of NVS stock, worth $416,815. This represents 0.1% of its overall portfolio holdings.

Number of Shares
4,044
Previous 4,044 -0.0%
Holding current value
$416,815
Previous $430,000 8.14%
% of portfolio
0.1%
Previous 0.1%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 03, 2024

BUY
$92.57 - $107.37 $374,353 - $434,204
4,044 New
4,044 $430,000
Q2 2023

Jul 05, 2023

BUY
$92.52 - $104.91 $378,776 - $429,501
4,094 New
4,094 $413,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $222B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Curbstone Financial Management Corp Portfolio

Follow Curbstone Financial Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Curbstone Financial Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Curbstone Financial Management Corp with notifications on news.